Molecular analysis of volatile metabolites released specifically by <it>staphylococcus aureus</it> and <it>pseudomonas aeruginosa</it>

<p>Abstract</p> <p>Background</p> <p>The routinely used microbiological diagnosis of ventilator associated pneumonia (VAP) is time consuming and often requires invasive methods for collection of human specimens (e.g. bronchoscopy). Therefore, it is of utmost interest to...

Full description

Bibliographic Details
Main Authors: Filipiak Wojciech, Sponring Andreas, Baur Maria, Filipiak Anna, Ager Clemens, Wiesenhofer Helmut, Nagl Markus, Troppmair Jakob, Amann Anton
Format: Article
Language:English
Published: BMC 2012-06-01
Series:BMC Microbiology
Subjects:
Online Access:http://www.biomedcentral.com/1471-2180/12/113
id doaj-5e24cc41a973428da10d8588874944d9
record_format Article
spelling doaj-5e24cc41a973428da10d8588874944d92020-11-25T01:33:48ZengBMCBMC Microbiology1471-21802012-06-0112111310.1186/1471-2180-12-113Molecular analysis of volatile metabolites released specifically by <it>staphylococcus aureus</it> and <it>pseudomonas aeruginosa</it>Filipiak WojciechSponring AndreasBaur MariaFilipiak AnnaAger ClemensWiesenhofer HelmutNagl MarkusTroppmair JakobAmann Anton<p>Abstract</p> <p>Background</p> <p>The routinely used microbiological diagnosis of ventilator associated pneumonia (VAP) is time consuming and often requires invasive methods for collection of human specimens (e.g. bronchoscopy). Therefore, it is of utmost interest to develop a non-invasive method for the early detection of bacterial infection in ventilated patients, preferably allowing the identification of the specific pathogens. The present work is an attempt to identify pathogen-derived volatile biomarkers in breath that can be used for early and non- invasive diagnosis of ventilator associated pneumonia (VAP). For this purpose, <it>in vitro</it> experiments with bacteria most frequently found in VAP patients, i.e. <it>Staphylococcus aureus</it> and <it>Pseudomonas aeruginosa</it>, were performed to investigate the release or consumption of volatile organic compounds (VOCs).</p> <p>Results</p> <p>Headspace samples were collected and preconcentrated on multibed sorption tubes at different time points and subsequently analyzed with gas chromatography mass spectrometry (GC-MS). As many as 32 and 37 volatile metabolites were released by <it>S. aureus</it> and <it>P. aeruginosa</it>, respectively. Distinct differences in the bacteria-specific VOC profiles were found, especially with regard to aldehydes (e.g. acetaldehyde, 3-methylbutanal), which were taken up only by <it>P. aeruginosa</it> but released by <it>S. aureus</it>. Differences in concentration profiles were also found for acids (e.g. isovaleric acid), ketones (e.g. acetoin, 2-nonanone), hydrocarbons (e.g. 2-butene, 1,10-undecadiene), alcohols (e.g. 2-methyl-1-propanol, 2-butanol), esters (e.g. ethyl formate, methyl 2-methylbutyrate), volatile sulfur compounds (VSCs, e.g. dimethylsulfide) and volatile nitrogen compounds (VNCs, e.g. 3-methylpyrrole).</p> <p>Importantly, a significant VOC release was found already 1.5 hours after culture start, corresponding to cell numbers of ~8*10<sup>6</sup> [CFUs/ml].</p> <p>Conclusions</p> <p>The results obtained provide strong evidence that the detection and perhaps even identification of bacteria could be achieved by determination of characteristic volatile metabolites, supporting the clinical use of breath-gas analysis as non-invasive method for early detection of bacterial lung infections.</p> http://www.biomedcentral.com/1471-2180/12/113Volatile organic compounds (VOCs)Gas chromatography mass spectrometry (GCMS)Breath analysis<it>In vitro</it> headspace samplingAdsorptive enrichmentMultibed sorption tubesVolatile metabolites<it>Staphylococcus aureus</it><it>Pseudomonas aeruginosa</it>
collection DOAJ
language English
format Article
sources DOAJ
author Filipiak Wojciech
Sponring Andreas
Baur Maria
Filipiak Anna
Ager Clemens
Wiesenhofer Helmut
Nagl Markus
Troppmair Jakob
Amann Anton
spellingShingle Filipiak Wojciech
Sponring Andreas
Baur Maria
Filipiak Anna
Ager Clemens
Wiesenhofer Helmut
Nagl Markus
Troppmair Jakob
Amann Anton
Molecular analysis of volatile metabolites released specifically by <it>staphylococcus aureus</it> and <it>pseudomonas aeruginosa</it>
BMC Microbiology
Volatile organic compounds (VOCs)
Gas chromatography mass spectrometry (GCMS)
Breath analysis
<it>In vitro</it> headspace sampling
Adsorptive enrichment
Multibed sorption tubes
Volatile metabolites
<it>Staphylococcus aureus</it>
<it>Pseudomonas aeruginosa</it>
author_facet Filipiak Wojciech
Sponring Andreas
Baur Maria
Filipiak Anna
Ager Clemens
Wiesenhofer Helmut
Nagl Markus
Troppmair Jakob
Amann Anton
author_sort Filipiak Wojciech
title Molecular analysis of volatile metabolites released specifically by <it>staphylococcus aureus</it> and <it>pseudomonas aeruginosa</it>
title_short Molecular analysis of volatile metabolites released specifically by <it>staphylococcus aureus</it> and <it>pseudomonas aeruginosa</it>
title_full Molecular analysis of volatile metabolites released specifically by <it>staphylococcus aureus</it> and <it>pseudomonas aeruginosa</it>
title_fullStr Molecular analysis of volatile metabolites released specifically by <it>staphylococcus aureus</it> and <it>pseudomonas aeruginosa</it>
title_full_unstemmed Molecular analysis of volatile metabolites released specifically by <it>staphylococcus aureus</it> and <it>pseudomonas aeruginosa</it>
title_sort molecular analysis of volatile metabolites released specifically by <it>staphylococcus aureus</it> and <it>pseudomonas aeruginosa</it>
publisher BMC
series BMC Microbiology
issn 1471-2180
publishDate 2012-06-01
description <p>Abstract</p> <p>Background</p> <p>The routinely used microbiological diagnosis of ventilator associated pneumonia (VAP) is time consuming and often requires invasive methods for collection of human specimens (e.g. bronchoscopy). Therefore, it is of utmost interest to develop a non-invasive method for the early detection of bacterial infection in ventilated patients, preferably allowing the identification of the specific pathogens. The present work is an attempt to identify pathogen-derived volatile biomarkers in breath that can be used for early and non- invasive diagnosis of ventilator associated pneumonia (VAP). For this purpose, <it>in vitro</it> experiments with bacteria most frequently found in VAP patients, i.e. <it>Staphylococcus aureus</it> and <it>Pseudomonas aeruginosa</it>, were performed to investigate the release or consumption of volatile organic compounds (VOCs).</p> <p>Results</p> <p>Headspace samples were collected and preconcentrated on multibed sorption tubes at different time points and subsequently analyzed with gas chromatography mass spectrometry (GC-MS). As many as 32 and 37 volatile metabolites were released by <it>S. aureus</it> and <it>P. aeruginosa</it>, respectively. Distinct differences in the bacteria-specific VOC profiles were found, especially with regard to aldehydes (e.g. acetaldehyde, 3-methylbutanal), which were taken up only by <it>P. aeruginosa</it> but released by <it>S. aureus</it>. Differences in concentration profiles were also found for acids (e.g. isovaleric acid), ketones (e.g. acetoin, 2-nonanone), hydrocarbons (e.g. 2-butene, 1,10-undecadiene), alcohols (e.g. 2-methyl-1-propanol, 2-butanol), esters (e.g. ethyl formate, methyl 2-methylbutyrate), volatile sulfur compounds (VSCs, e.g. dimethylsulfide) and volatile nitrogen compounds (VNCs, e.g. 3-methylpyrrole).</p> <p>Importantly, a significant VOC release was found already 1.5 hours after culture start, corresponding to cell numbers of ~8*10<sup>6</sup> [CFUs/ml].</p> <p>Conclusions</p> <p>The results obtained provide strong evidence that the detection and perhaps even identification of bacteria could be achieved by determination of characteristic volatile metabolites, supporting the clinical use of breath-gas analysis as non-invasive method for early detection of bacterial lung infections.</p>
topic Volatile organic compounds (VOCs)
Gas chromatography mass spectrometry (GCMS)
Breath analysis
<it>In vitro</it> headspace sampling
Adsorptive enrichment
Multibed sorption tubes
Volatile metabolites
<it>Staphylococcus aureus</it>
<it>Pseudomonas aeruginosa</it>
url http://www.biomedcentral.com/1471-2180/12/113
work_keys_str_mv AT filipiakwojciech molecularanalysisofvolatilemetabolitesreleasedspecificallybyitstaphylococcusaureusitanditpseudomonasaeruginosait
AT sponringandreas molecularanalysisofvolatilemetabolitesreleasedspecificallybyitstaphylococcusaureusitanditpseudomonasaeruginosait
AT baurmaria molecularanalysisofvolatilemetabolitesreleasedspecificallybyitstaphylococcusaureusitanditpseudomonasaeruginosait
AT filipiakanna molecularanalysisofvolatilemetabolitesreleasedspecificallybyitstaphylococcusaureusitanditpseudomonasaeruginosait
AT agerclemens molecularanalysisofvolatilemetabolitesreleasedspecificallybyitstaphylococcusaureusitanditpseudomonasaeruginosait
AT wiesenhoferhelmut molecularanalysisofvolatilemetabolitesreleasedspecificallybyitstaphylococcusaureusitanditpseudomonasaeruginosait
AT naglmarkus molecularanalysisofvolatilemetabolitesreleasedspecificallybyitstaphylococcusaureusitanditpseudomonasaeruginosait
AT troppmairjakob molecularanalysisofvolatilemetabolitesreleasedspecificallybyitstaphylococcusaureusitanditpseudomonasaeruginosait
AT amannanton molecularanalysisofvolatilemetabolitesreleasedspecificallybyitstaphylococcusaureusitanditpseudomonasaeruginosait
_version_ 1725075723923750912